In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.

The efficacy of trovafloxacin in treating Bacteroides fragilis and Escherichia coli infections was investigated and compared to the efficacy of combined clindamycin and gentamicin therapy in an experimental model of intra-abdominal abscesses in rats. Rats were treated with different doses of CP-116,...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Antimicrob Agents Chemother
Principais autores:	Thadepalli, H, Reddy, U, Chuah, S K, Thadepalli, F, Malilay, C, Polzer, R J, Hanna, N, Esfandiari, A, Brown, P, Gollapudi, S
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Microbiology (ASM) 1997
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163755/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9055997/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.3.583
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!